Feedback
Leucine Aminopeptidase (LAP), Serum
0080301
Ordering Recommendation

Screen for obstructive biliary disease.

Mnemonic
LAP B
Methodology
Quantitative Spectrophotometry
Performed
Fri
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Serum separator tube. Also acceptable: Green (sodium or lithium heparin), lavender (EDTA), pink (K2EDTA), or lt. blue (sodium citrate). 
Specimen Preparation
Allow serum specimen to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 2 hours of collection. Transport 1 mL serum or plasma. (Min: 0.5 mL) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 4 days; Refrigerated: 1 week; Frozen: 3 weeks 
Reference Interval
Male: 1.1-3.4 U/mL
Female: 1.2-3.0 U/mL
Interpretive Data


Components
Component Test Code*Component Chart NameLOINC
0080301Leucine Aminopeptidase, Serum2187-3
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • LAP
  • Leucine Aminopeptidase